OptiBiotix Health (LON:OPTI) Hits New 1-Year Low – Here’s What Happened

Shares of OptiBiotix Health Plc (LON:OPTI) reached a new 52-week low during trading on Thursday . The stock traded as low as GBX 6.50 and last traded at GBX 6.99, with a volume of 118340 shares trading hands. The stock had previously closed at GBX 6.75.

OptiBiotix Health Price Performance

The stock has a market capitalization of £7.22 million, a P/E ratio of -232.83 and a beta of 1.71. The stock’s fifty day moving average is GBX 8.03 and its two-hundred day moving average is GBX 10.14.

OptiBiotix Health (LON:OPTI) last posted its quarterly earnings results on Tuesday, September 16th. The company reported GBX (1.15) earnings per share (EPS) for the quarter. OptiBiotix Health had a negative net margin of 524.43% and a negative return on equity of 36.76%.

Insiders Place Their Bets

In related news, insider Stephen O’Hara bought 95,238 shares of OptiBiotix Health stock in a transaction dated Tuesday, September 23rd. The stock was acquired at an average cost of GBX 11 per share, with a total value of £10,476.18. Also, insider David Blain purchased 84,053 shares of the firm’s stock in a transaction that occurred on Wednesday, October 1st. The stock was bought at an average price of GBX 1,175 per share, with a total value of £987,622.75. Insiders have bought 229,291 shares of company stock worth $100,309,893 over the last ninety days. 26.82% of the stock is owned by insiders.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.